Jun 19, 2026 · 7 min
US export probe pressures ASML while Novo Nordisk and Vestas rally
ASML Dips, Novo Jumps, Vestas Gains
Geopolitical trade tensions and analyst upgrades are rapidly redefining the valuation of Europe's most prominent technology, healthcare, and energy companies.
- 1ASML faces stock pressure amid a US investigation into potential export restriction violations involving chipmaking equipment in China.
- 2Novo Nordisk shares jumped following a Nordea upgrade to buy and the launch of new research incubators.
- 3Vestas gained market ground after JPMorgan Chase placed the wind turbine manufacturer on a positive catalyst watch.
The brief
European equity markets are seeing sharp divergence as regulatory pressure and financial upgrades reshape the outlook for major semiconductor, pharmaceutical, and clean energy players.
Dutch chipmaking giant ASML faces downward pressure as US authorities investigate potential violations of export restrictions regarding the shipment of its advanced equipment to China.
Meanwhile, Danish pharmaceutical leader Novo Nordisk received a significant boost following a buy upgrade from Nordea alongside the launch of new research incubators.
Wind turbine manufacturer Vestas also gained positive momentum after JPMorgan analysts placed the clean energy company on a positive catalyst watch.
What was said on this episode
4 statements · 3 positive · 1 negative
The ASML dispute may further strain EU-US relations.
“this may also strain this quite difficult relationship between the EU and the US Even further.”
Listen at 2:02
Novo Nordisk stock is reacting positively to the foundation initiative.
“Novo is, is reacting to that positively this morning.”
Listen at 3:44
This year could be favorable for some wind companies.
“Overall, this year could be pretty good for some of those wind companies.”
Listen at 4:38
Wind-company orders will continue into 2027, providing visibility for several years.
“that means orders are going to continue into 2027 and that really guarantees visibility over at least the next few years.”
Listen at 4:56
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
ASML
Novo NordiskBooks & mentions
Bloomberg Stock Movers Report
Stay updated on the daily market shifts driving global equity markets
Listen to the full episode and explore every guest, topic, and moment on PodLume.